REGENERON PHARMACEUTICALS, INC. ($REGN)
Filing Information
| Accession Number | 0001681643-26-000002 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 6, 2026 |
| Document Date | Jan 2, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
2,117
Total Value
$0.00
P&L
+inf% (+$1,640,950.21)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Jan 2, 2026 | Grant/Award | 155 | $0.00 | $0.00 | 1,703 | Direct | โ | View Details | |
Director | Non-Qualified Stock Option (right to buy) | Derivative | Jan 2, 2026 | Grant/Award | 1,962 | $0.00 | $0.00 | 1,962 | Direct | โ | View Details |